John Crowley
2020
In 2020, John Crowley earned a total compensation of $1.6M as Chief Financial Officer at Fusion Pharmaceuticals, a 88% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $196,597 |
|---|---|
| Option Awards | $951,608 |
| Salary | $437,795 |
| Other | $12,040 |
| Total | $1,598,040 |
Crowley received $951.6K in option awards, accounting for 60% of the total pay in 2020.
Crowley also received $196.6K in non-equity incentive plan, $437.8K in salary and $12K in other compensation.
Rankings
In 2020, John Crowley's compensation ranked 6,559th out of 13,090 executives tracked by ExecPay. In other words, Crowley earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,559 out of 13,090 | 50th |
Division Manufacturing | 2,713 out of 5,621 | 52nd |
Major group Chemicals And Allied Products | 1,093 out of 2,254 | 52nd |
Industry group Drugs | 947 out of 1,954 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 226 out of 411 | 45th |
Source: SEC filing on April 27, 2021.
Crowley's colleagues
We found three more compensation records of executives who worked with John Crowley at Fusion Pharmaceuticals in 2020.